www.fdanews.com/articles/86706-aastrom-3q-loss-widens-37-percent
AASTROM 3Q LOSS WIDENS 37 PERCENT
May 10, 2006
Aastrom Biosciences Inc., which develops stem cell-based tissue-regeneration products, said Wednesday its third-quarter loss widened 37 percent as expenses increased, and announced it can now start
making products at its German plant.
The Houston Chronicle